Literature DB >> 20144262

The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.

Pollyanna A Tat1, Huseyin Sumer, Karen L Jones, Kyle Upton, Paul J Verma.   

Abstract

Ectopic expression of key reprogramming transgenes in somatic cells enables them to adopt the characteristics of pluripotency. Such cells have been termed induced pluripotent stem (iPS) cells and have revolutionized the field of somatic cell reprogramming, as the need for embryonic material is obviated. One of the issues facing both the clinical translation of iPS cell technology and the efficient derivation of iPS cell lines in the research laboratory is choosing the most appropriate somatic cell type for induction. In this study, we demonstrate the direct reprogramming of a defined population of neural stem cells (NSCs) derived from the subventricular zone (SVZ) and adipose tissue-derived cells (ADCs) from adult mice using retroviral transduction of the Yamanaka factors Oct4, Sox2, Klf4, and c-Myc, and compared the results obtained with a mouse embryonic fibroblast (mEF) control. We isolated mEFs, NSCs, and ADCs from transgenic mice, which possess a GFP transgene under control of the Oct4 promoter, and validated GFP expression as an indicator of reprogramming. While transduction efficiencies were not significantly different among the different cell types (mEFs 68.70 +/- 2.62%, ADCs 70.61 +/- 15.4%, NSCs, 68.72 +/- 3%, p = 0.97), the number of GFP-positive colonies and hence the number of reprogramming events was significantly higher for both NSCs (13.50 +/- 4.10 colonies, 0.13 +/- 0.06%) and ADCs (118.20 +/- 38.28 colonies, 1.14 +/- 0.77%) when compared with the mEF control (3.17 +/- 0.29 colonies, 0.03 +/- 0.005%). ADCs were most amenable to reprogramming with an 8- and 38-fold greater reprogramming efficiency than NSCs and mEFs, respectively. Both NSC iPS and ADC iPS cells were demonstrated to express markers of pluripotency and could differentiate to the three germ layers, both in vitro and in vivo, to cells representative of the three germ lineages. Our findings confirm that ADCs are an ideal candidate as a readily accessible somatic cell type for high efficiency establishment of iPS cell lines.

Entities:  

Mesh:

Year:  2010        PMID: 20144262     DOI: 10.3727/096368910X491374

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  33 in total

Review 1.  Neurological disorders and the potential role for stem cells as a therapy.

Authors:  Paul R Sanberg; David J Eve; L Eduardo Cruz; Cesar V Borlongan
Journal:  Br Med Bull       Date:  2012-02-21       Impact factor: 4.291

Review 2.  Adipose-derived stem cells for myocardial infarction.

Authors:  Manuel Mazo; Juan José Gavira; Beatriz Pelacho; Felipe Prosper
Journal:  J Cardiovasc Transl Res       Date:  2010-11-30       Impact factor: 4.132

Review 3.  Induced pluripotent stem cells: emerging techniques for nuclear reprogramming.

Authors:  Ji Woong Han; Young-Sup Yoon
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

4.  Optimization of agitation speed in spinner flask for microcarrier structural integrity and expansion of induced pluripotent stem cells.

Authors:  Priyanka Gupta; Mohd-Zulhilmi Ismadi; Paul J Verma; Andreas Fouras; Sameer Jadhav; Jayesh Bellare; Kerry Hourigan
Journal:  Cytotechnology       Date:  2014-07-26       Impact factor: 2.058

Review 5.  In vitro neurogenesis: development and functional implications of iPSC technology.

Authors:  Claudia Compagnucci; Monica Nizzardo; Stefania Corti; Ginevra Zanni; Enrico Bertini
Journal:  Cell Mol Life Sci       Date:  2013-11-20       Impact factor: 9.261

6.  Integration-Free Human Induced Pluripotent Stem Cells From Type 1 Diabetes Patient Skin Fibroblasts Show Increased Abundance of Pancreas-Specific microRNAs.

Authors:  Jun Liu; Mugdha V Joglekar; Huseyin Sumer; Anandwardhan A Hardikar; Halena Teede; Paul J Verma
Journal:  Cell Med       Date:  2014-05-02

7.  Non-viral expression of mouse Oct4, Sox2, and Klf4 transcription factors efficiently reprograms tadpole muscle fibers in vivo.

Authors:  Céline Vivien; Pierluigi Scerbo; Fabrice Girardot; Karine Le Blay; Barbara A Demeneix; Laurent Coen
Journal:  J Biol Chem       Date:  2012-01-09       Impact factor: 5.157

Review 8.  Tissue-Restricted Stem Cells as Starting Cell Source for Efficient Generation of Pluripotent Stem Cells: An Overview.

Authors:  Pradeep Kumar Sundaravadivelu; Khyati Raina; Madhuri Thool; Arnab Ray; Jahnavy Madhukar Joshi; Vishwas Kaveeshwar; S Sudhagar; Nibedita Lenka; Rajkumar P Thummer
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

9.  Roles of p53 and ASF1A in the Reprogramming of Sheep Kidney Cells to Pluripotent Cells.

Authors:  Huijun Shi; Qiang Fu; Guozhong Li; Yan Ren; Shengwei Hu; Wei Ni; Fei Guo; Mengting Shi; Luping Meng; Hui Zhang; Jun Qiao; Zhiru Guo; Chuangfu Chen
Journal:  Cell Reprogram       Date:  2015-11-18       Impact factor: 1.987

10.  Harnessing the anti-inflammatory properties of stem cells for transplant therapy in hemorrhagic stroke.

Authors:  Sydney Corey; Brooke Bonsack; Matt Heyck; Alex Shear; Nadia Sadanandan; Henry Zhang; Cesar V Borlongan
Journal:  Brain Hemorrhages       Date:  2020-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.